Genetic interactions between Pten and p53 in radiation-induced lymphoma development

Oncogene

Volumn 22, Issue 52, 2003, Pages 8379-8385

  Mao, Jian Hua ^a   Wu, Di ^a   Perez Losada, Jesus ^a   Nagase, Hiroki ^b   DelRosario, Reyno ^a   Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Intragenic deletion; Loss of heterozygosity; p53; Pten; Radiation induced lymphoma

Indexed keywords

MICROSATELLITE DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ALLELE; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHROMOSOME 19; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INTERACTION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PTEN GENE; RADIATION EXPOSURE; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, WESTERN; LOSS OF HETEROZYGOSITY; LYMPHOMA; MICE; NEOPLASMS, RADIATION-INDUCED; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0347383877     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207083     Document Type: Article

References (32)

1. Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR. (1998). J. Biol. Chem., 273, 1-4.
2. Ali IU, Schriml L M and Dean M. (1999). J. Natl. Cancer Inst., 9, 1922-1932.
3. Butler MP, Wang SI, Chaganti RS, Parsons R and Dalla-Favera R. (1999). Genes Chromosomes Cancer, 24, 322-327.
4. Cai WW, Mao JH, Chow CW, Damani S, Balmain A and Bradley A. (2002). Nat. Biotechnol., 20, 393-396.
5. Caspari T. (2000). Curr. Biol., 10, R315-R317.
6. Dahia PL, Aguiar RC, Alberta J, Kum JB, Caron S, Sill H, Marsh DJ, Ritz J, Freedman A, Stiles C and Eng C. (1999). Hum. Mol. Genet., 8, 185-193.
7. Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP. (1998). Nat. Genet., 19, 348-355.
8. el-Deiry WS. (1998). Semin. Cancer Biol., 8, 345-357.
9. Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ. (1998). Nature, 396, 177-180.
10. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X and Wu H. (2003). Cancer Cell, 3, 117-130.
11. Frisk T, Foukakis T, Dwight T, Lundberg J, Hoog A, Wallin G, Eng C, Zedenius J and Larsson C. (2002). Genes Chromosomes Cancer, 35, 74-80.
12. Gronbaek K, Zeuthen J, Guldberg P, Ralfkiaer E and Hou-Jensen K. (1998). Blood, 91, 4388-4390.
13. Herranz M, Urioste M, Santos J, Martinez-Delgado JB, Rivas C, Benitez J and Fernandez-Piqueras J. (2000). Leukemia, 14, 1325-1327.
14. Izumoto S, Ohnishi T, Kanemura H, Arita N, Maruno M, Moriuchi T, Suzuki S and Yoshimine T. (2001). J. Neurooncol., 53, 21-26.
15. Kemp CJ, Wheldon T and Balmain A. (1994). Nat. Genet., 8, 66-69.
16. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP and Eng C. (2002). Nat. Genet., 32, 355-357.
17. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N and Ittmann M. (2001). Proc. Natl. Acad. Sci. USA, 98, 11563-11568.
18. Lakin ND and Jackson SP. (1999). Oncogene, 18, 7644-7655.
19. Leslie NR and Downes CP. (2002). Cell Signal., 14, 285-295.
20. Mayo LD and Donner DB. (2002). Trends Biochem. Sci., 27, 462-467.
21. Mayo LD, Dixon JE, Durden DL, Tonks NK and Donner DB. (2002). J. Biol. Chem., 277, 5484-5489.
22. Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y and Ben-Ze'ev A. (2002). Biochem. Pharmacol., 64, 865-871.
23. Santos J, Herranz M, Fernandez M, Vaquero C, Lopez P and Fernandez-Piqueras J. (2001). Oncogene, 20, 2186-2189.
24. Santos J, Montagutelli X, Acevedo A, Lopez P, Vaquero C, Fernandez M, Arnau MR, Szatanik M, Salido E, Guenet JL and Fernandez-Piqueras J. (2002). Oncogene, 21, 6680-6683.
25. Shin KH, Kim JM, Rho KS, Park KH, Oh JE and Min BM. (2002). Int. J. Oncol., 21, 997-1001.
26. Sjoling A, Samuelson E, Adamovic T, Behboudi A, Rohme D and Levan G. (2003). Genes Chromosomes Cancer, 36, 70-79.
27. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S and Mak TW. (2001). Mol. Cell, 8, 317-325.
28. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M and Mak TW. (1998). Curr. Biol., 8, 1169-1178.
29. Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ and Wakefield LM. (1998). Nat. Med., 4, 802-807.
30. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T and de Belle I. (2001). Nat. Cell Biol., 3, 1124-1128.
31. Waite KA and Eng C. (2002). Am. J. Hum. Genet., 70, 829-884.
32. Wick W, Furnari FB, Naumann U, Cavenee WK and Weller M. (1999). Oncogene, 18, 3936-3943.